Search Results - "Chulkina, Marina"
-
1
Role of PD-L1 in Gut Mucosa Tolerance and Chronic Inflammation
Published in International journal of molecular sciences (01-12-2020)“…The gastrointestinal (GI) mucosa is among the most complex systems in the body. It has a diverse commensal microbiome challenged continuously by food and…”
Get full text
Journal Article -
2
Drug-Microbiota Interaction in Colon Cancer Therapy: Impact of Antibiotics
Published in Biomedicines (05-03-2021)“…Colon adenocarcinoma is one of the most common malignancies, and it is highly lethal. Chemotherapy plays an important role in the treatment of colon cancer at…”
Get full text
Journal Article -
3
The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vector
Published in BMC immunology (28-07-2018)“…Agonists of TLR3 and TLR4 are effective immunoadjuvants for different types of vaccines. The mechanisms of their immunostimulatory action differ significantly;…”
Get full text
Journal Article -
4
-
5
Tu1816 JAK2/STAT SIGNALING: ROLE IN GENERATION OF INFLAMMATORY MESENCHYMAL CELLS IN ULCERATIVE COLITIS
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2023)Get full text
Journal Article -
6
-
7
INCREASE IN MK2 ACTIVITY IN CROHN’S DISEASE: ROLE IN THE INFLAMMATORY ACTIVATION OF FIBROBLASTS
Published in Gastroenterology (New York, N.Y. 1943) (01-02-2022)Get full text
Journal Article -
8
ACTIVATION OF MK2 IN CROHN’S DISEASE-ASSOCIATED FIBROSIS: NEW TARGET FOR ANTI-FIBROTIC THERAPY
Published in Gastroenterology (New York, N.Y. 1943) (01-02-2022)Get full text
Journal Article -
9
344 ACTIVATION OF MK2-TTP SIGNALING AS A DRIVER OF PATHOLOGICAL CHANGES IN INTESTINAL FIBROBLASTS IN CROHN'S DISEASE
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2023)Get full text
Journal Article -
10
174 BRD4 AS A POTENTIAL THERAPEUTIC TARGET FOR CROHN'S DISEASEASSOCIATED FIBROSIS
Published in Gastroenterology (New York, N.Y. 1943) (18-05-2024)Get full text
Journal Article -
11
INCREASE IN MK2 ACTIVITY IN CROHN’S DISEASE: ROLE IN THE INFLAMMATORY ACTIVATION OF FIBROBLASTS
Published in Inflammatory bowel diseases (22-01-2022)“…Abstract INTRODUCTION AND HYPOTHESIS Mesenchymal cells known as myo-/fibroblasts (MFs) are critical immunosuppressors under gut mucosal homeostasis. Expression…”
Get full text
Journal Article -
12
ACTIVATION OF MK2 IN CROHN’S DISEASE-ASSOCIATED FIBROSIS: NEW TARGET FOR ANTI-FIBROTIC THERAPY
Published in Inflammatory bowel diseases (22-01-2022)“…Abstract INTRODUCTION Fibrosis is the major aggressive complication of Crohn’s disease (CD), causing intestinal obstruction. No targeted therapies are…”
Get full text
Journal Article -
13
457: INCREASE IN MK2 ACTIVITY IN CROHN'S DISEASE: ROLE IN THE INFLAMMATORY ACTIVATION OF FIBROBLASTS
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2022)Get full text
Journal Article -
14
11: BRD4-MK2 SIGNALING: TARGET FOR CROHN'S DISEASE-ASSOCIATED FIBROSIS
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2022)Get full text
Journal Article -
15
MyD88-mediated signaling in myo-/fibroblasts is required for control of macrophage maturation under mucosal tolerance in the gut
Published in The Journal of immunology (1950) (01-05-2022)“…Abstract Introduction Colonic myo-/fibroblasts (MFs) are cells of mesenchymal origin in a healthy gut are among the key players in the mucosal tolerance that…”
Get full text
Journal Article -
16
Disruption of retinol-mediated IL-6 expression in colon cancer-associated fibroblasts: new perspectives on the role of vitamin A metabolism
Published in Oncotarget (26-04-2023)“…Stromal myo-/fibroblasts (MFs) account for up to 30% of lamina propria cells in the normal human colon and their number is dramatically increased in colon…”
Get full text
Journal Article -
17
BRD4‐MK2 signaling: target for Crohn’s Disease‐associated fibrosis
Published in The FASEB journal (01-05-2022)“…Introduction Fibrosis is the major complication of Crohn’s disease (CD). No targeted therapies are currently available to revert CD‐associated fibrosis. While…”
Get full text
Journal Article -
18
Synthetic peptide TEKKRRETVEREKE derived from ezrin induces differentiation of NIH/3T3 fibroblasts
Published in European journal of pharmacology (15-09-2017)“…Synthetic 14 AA peptide (Gepon) derived from the hinge region of ezrin, a protein that links cell surface molecules to intracellular actin filaments,…”
Get full text
Journal Article -
19
Loss of alcohol dehydrogenase 1B in cancer-associated fibroblasts: contribution to the increase of tumor-promoting IL-6 in colon cancer
Published in British journal of cancer (16-02-2023)“…Background Increases in IL-6 by cancer-associated fibroblasts (CAFs) contribute to colon cancer progression, but the mechanisms involved in the increase of…”
Get full text
Journal Article -
20
Increased Activity of MAPKAPK2 within Mesenchymal Cells as a Target for Inflammation-Associated Fibrosis in Crohn's Disease
Published in Journal of Crohn's and colitis (06-08-2024)“…Mesenchymal stromal cells are suggested to play a critical role in Crohn's disease [CD]-associated fibrosis. MAPKAPK2 [MK2] has emerged as a potential…”
Get full text
Journal Article